Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Icecure Medical FY EPS $(0.32), Inline, Sales $3.23M Beat $3.14M Estimate

Author: Benzinga Newsdesk | April 03, 2024 08:33am
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 30.43 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $3.23 million which beat the analyst consensus estimate of $3.14 million by 2.83 percent. This is a 4.67 percent increase over sales of $3.08 million the same period last year.

Posted In: ICCM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist